Latest Articles
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer - Cancer Health
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer Cancer Health
Published: Jan. 15, 2026, 1:34 p.m.
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers - koreabiomed.com
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers koreabiomed.com
Published: Jan. 15, 2026, 6:21 a.m.
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News
Published: Jan. 14, 2026, 7:32 p.m.
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity TipRanks
Published: Jan. 14, 2026, 4:33 p.m.
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma springermedicine.com
Published: Jan. 14, 2026, 6:02 a.m.
More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 New York
More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 New York
Published: Jan. 13, 2026, 6:07 p.m.
More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 Los Angeles
More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 Los Angeles
Published: Jan. 13, 2026, 5:02 p.m.
More people are living 5 years after cancer diagnosis, new ACS data shows - ABC30 Fresno
More people are living 5 years after cancer diagnosis, new ACS data shows ABC30 Fresno
Published: Jan. 13, 2026, 5:02 p.m.
ASCO 2025: key highlights in endometrial cancer - springermedicine.com
ASCO 2025: key highlights in endometrial cancer springermedicine.com
Published: Jan. 13, 2026, 5:23 a.m.
Therapeutic potential of epigallocatechin gallate in gynecologic cancer, endometriosis, polycystic ovary syndrome: a mechanistic and translational perspective.
Tea, among the most widely consumed beverages worldwide, is rich in polyphenolic compounds known as catechins, particularly epigallocatechin gallate (EGCG). This review aims to synthesize recent findings and ongoing controversies …
Published: Jan. 13, 2026, midnight
Link copied to clipboard!